Norges Bank’s Tectonic Therapeutic TECX Stock Holding History

Norges Bank’s Portfolio TECX Stock Details TECX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1,250	Closed	-$428K	–	2171
2018 Q2	$428K	Buy	+1,250	New	+$451K	﹤0.01%	2096

Other funds holding TECX

Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Norges Bank's TECX Position: Q3 2018 in Review

Norges Bank sold out of Tectonic Therapeutic (TECX) in Q3 2018, closing a stake of 1,250 shares — an estimated $428K sold.

Norges Bank first reported a position in TECX in Q2 2018 and held it in 1 quarter. The position peaked at $428K in Q2 2018. 63 funds tracked by Wall St. Rank hold TECX as of Q3 2018.

Norges Bank reported no remaining Tectonic Therapeutic position as of Q3 2018 after selling out during the quarter.
Norges Bank sold 1,250 Tectonic Therapeutic shares in Q3 2018, an estimated $428K.
Norges Bank first reported a position in Tectonic Therapeutic in Q2 2018 and held it in 1 quarter.
Norges Bank's Tectonic Therapeutic position peaked at $428K in Q2 2018.
63 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q3 2018.

Based on Norges Bank's 13F filing for Q3 2018, filed 9 Nov 2018.